UK NICE · June 15, 2026

NICE guidance on faecal immunochemical test for bowel cancer referrals

Original title: How the faecal immunochemical test is changing bowel cancer referrals and what it tells us about the power of NICE guidance

NICE guidance on faecal immunochemical testing is reducing unnecessary urgent referrals by 140,000 annually while maintaining cancer detection rates.

Medium impact Digital Health & AI Market Access & Reimbursement UK samdclinical-evaluationreimbursement

Learn how NICE's healthtech guidance is accelerating NHS adoption of a simple bowel cancer test, preventing 140,000 unnecessary urgent referrals a year while keeping cancer detection rates stable.

Read the official source ↗

Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.